Compare Motorola Solutions Inc (MSI) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Motorola Solutions Inc vs Oruka Therapeutics Inc. Common Stock — how do they compare? Motorola Solutions Inc trades at $455.97 (market cap $74.76B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B). The key difference: Motorola Solutions Inc is far larger — about 14.7× Oruka Therapeutics Inc. Common Stock's market cap, and Motorola Solutions Inc pays a 1.07% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Motorola Solutions Inc for 101 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| MSI | ORKA | |
|---|---|---|
Market Cap | $74.76B | $5.08B |
Volume | 541,174 | 685,276 |
Sector | Technology | Health |
52-Week High | $491.24 | $113.08 |
52-Week Low | $363.83 | $26.19 |
Typical Hold Time | 101 Days | 0 Days |
Enterprise Value | $83.67B | $4.21B |
Dividend Yield | 1.07% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Motorola Solutions (MSI) trades at $449.01, up 0.64% today, with a neutral technical signal. The company shows strong fundamentals: revenue grew to $11.68B in 2025, net income margin is 17.44%, and it has beaten EPS estimates for three consecutive quarters. Recent news includes a $1.5B acquisition of D-Fend Solutions and a $139M public safety contract in Louisiana, highlighting growth in defense and security segments. Cash flow from operations is robust at $2.84B, though net cash flow was negative due to significant investing activities.
Outlook is positive given analyst consensus of a $525.86 price target and 70.59% buy ratings, supported by record backlog and strategic acquisitions. Risks include high valuation multiples (P/E 35.38) and increased debt levels, with net cash flow turning negative in 2025-2026. The stock offers growth potential in mission-critical solutions but faces execution risks from integration of recent buys and competitive pressures.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
